FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32887711000001102: Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jul 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100214101000001116 Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100214201000001111 Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Is a Daratumumab 400mg/20ml solution for infusion vials true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient Daratumumab false Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Is a Darzalex true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has active ingredient Monoclonal antibody true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient Daratumumab true Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has AMP True Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start